Comparison between nucleic acid amplification tests, antigen immunofluorescence assay, and in vitro infectivity in SARS-CoV-2 diagnosis

Braz J Microbiol. 2022 Sep;53(3):1271-1277. doi: 10.1007/s42770-022-00758-6. Epub 2022 Apr 21.

Abstract

The number of SARS-CoV-2 detection tests requested to the laboratories has dramatically increased together with an urgent need to release reliable responses in a very short time. The two options taken into consideration and analyzed in the current study were the point-of-care test (POCT) based on the nucleic acid amplification test (NAAT) and the Antigen (Ag) rapid test. The POCT-NAAT-based assay was compared with a rapid antigen test of nasopharyngeal swab samples. If the specimen tested positive, it was followed by viral load quantification and by the functional assessment of the residual infectivity. When the initial cycle threshold (Ct) was below 20 (100%), and in the range of 20-25 (92%) and of 25-30 (88%), a great concordance between the POCT-NAAT and the Ag test was observed. Moreover, the positivity of the antigen test was well correlated to a successful infection in vitro (78%), with greater concordance when the initial Ct below 20 or above 35 (100%) and in the range 20-25 (83%). Our findings showed that most of the swabs which tested positive using the antigen test were able to infect the cells in vitro, suggesting that probably only these samples hold residual infectivity and therefore an increased risk of virus transmission at the moment of being tested.

Keywords: Antigen test; Nucleic acid amplification test; SARS-CoV-2.

MeSH terms

  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Fluorescent Antibody Technique
  • Humans
  • Nucleic Acid Amplification Techniques
  • SARS-CoV-2* / genetics
  • Sensitivity and Specificity